ATE510008T1 - Entzündungshemmende peptide - Google Patents

Entzündungshemmende peptide

Info

Publication number: ATE510008T1
Authority: AT; Austria
Prior art keywords: peptide; seq; present; acid sequence; amino acid
Prior art date: 2005-12-06

Application number

AT06820396T

Other languages

English (en)

Inventor

Marie Cumberbatch

Rebecca Dearman

Ian Kimber

Russell Viner

Original Assignee

Univ Manchester

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-06

Filing date

2006-12-04

Publication date

2011-06-15

2006-12-04 Application filed by Univ Manchester filed Critical Univ Manchester

2011-06-15 Application granted granted Critical

2011-06-15 Publication of ATE510008T1 publication Critical patent/ATE510008T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
230000003110 anti-inflammatory effect Effects 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
239000013566 allergen Substances 0.000 abstract 2
125000003275 alpha amino acid group Chemical group 0.000 abstract 2
150000001413 amino acids Chemical class 0.000 abstract 2
230000012292 cell migration Effects 0.000 abstract 2
230000002757 inflammatory effect Effects 0.000 abstract 2
230000002401 inhibitory effect Effects 0.000 abstract 2
210000001821 langerhans cell Anatomy 0.000 abstract 2
210000003491 skin Anatomy 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT06820396T 2005-12-06 2006-12-04 Entzündungshemmende peptide ATE510008T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0524884.4A GB0524884D0 (en)	2005-12-06	2005-12-06	Improvements in or relating to organic compounds
PCT/GB2006/004510 WO2007066081A1 (en)	2005-12-06	2006-12-04	Anti-inflammatory peptides

Publications (1)

Publication Number	Publication Date
ATE510008T1 true ATE510008T1 (de)	2011-06-15

Family

ID=35686177

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06820396T ATE510008T1 (de)	2005-12-06	2006-12-04	Entzündungshemmende peptide

Country Status (9)

Country	Link
US (1)	US8188053B2 (de)
EP (1)	EP1960515B1 (de)
JP (1)	JP5280855B2 (de)
CN (1)	CN101384709B (de)
AT (1)	ATE510008T1 (de)
DK (1)	DK1960515T3 (de)
ES (1)	ES2366715T3 (de)
GB (1)	GB0524884D0 (de)
WO (1)	WO2007066081A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0524884D0 (en)	2005-12-06	2006-01-11	Syngenta Ltd	Improvements in or relating to organic compounds
KR102026800B1 (ko) *	2012-11-13	2019-09-30	(주)아모레퍼시픽	티오레독신을 함유하는 피부 외용제 조성물
EP3648785A4 (de) *	2017-07-05	2021-05-05	Jiangyin Usun Pharmaceutical Co., Ltd.	Entzündungshemmende verwendung von peptid
US11364321B2 (en)	2017-10-11	2022-06-21	Arizona Board Of Regents On Behalf Of Arizona State University	Nano scale decoration of scaffold-free microtissue using functionalised gold nanostructures
WO2023119230A1 (en)	2021-12-22	2023-06-29	L'oreal	Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9501067D0 (sv) *	1995-03-24	1995-03-24	Astra Ab	New peptides
EP0923604A1 (de) *	1996-04-12	1999-06-23	Astra Aktiebolag	Cystein- oder methioninhaltige peptide mit immunmodulierenden wirkungen
WO1999019347A1 (en) *	1997-10-10	1999-04-22	Astrazeneca Ab	Synthetic genes with immunomodulatory effects
AU3239400A (en) *	1999-02-22	2000-09-04	University Of Iowa Research Foundation, The	Method for inhibiting inflammatory responses
EP1346056A1 (de) *	2000-12-19	2003-09-24	SemBioSys Genetics Inc.	Methode zur herstellung von multimeren proteinen, und dazugehörende zusammensetzungen
EP1616948A4 (de) *	2003-03-31	2006-11-15	Nat Inst Of Advanced Ind Scien	Thioredoxinmodifikation
US7183381B2 (en) *	2004-10-26	2007-02-27	Agennix, Inc.	Composition of lactoferrin related peptides and uses thereof
GB0524884D0 (en)	2005-12-06	2006-01-11	Syngenta Ltd	Improvements in or relating to organic compounds

2005
- 2005-12-06 GB GBGB0524884.4A patent/GB0524884D0/en not_active Ceased
2006
- 2006-12-04 ES ES06820396T patent/ES2366715T3/es active Active
- 2006-12-04 AT AT06820396T patent/ATE510008T1/de not_active IP Right Cessation
- 2006-12-04 CN CN2006800461980A patent/CN101384709B/zh not_active Expired - Fee Related
- 2006-12-04 EP EP06820396A patent/EP1960515B1/de not_active Not-in-force
- 2006-12-04 WO PCT/GB2006/004510 patent/WO2007066081A1/en not_active Ceased
- 2006-12-04 US US12/086,210 patent/US8188053B2/en not_active Expired - Fee Related
- 2006-12-04 DK DK06820396.7T patent/DK1960515T3/da active
- 2006-12-04 JP JP2008543886A patent/JP5280855B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2366715T3 (es)	2011-10-24
EP1960515B1 (de)	2011-05-18
WO2007066081A1 (en)	2007-06-14
DK1960515T3 (da)	2011-09-05
JP5280855B2 (ja)	2013-09-04
US20090253631A1 (en)	2009-10-08
EP1960515A1 (de)	2008-08-27
US8188053B2 (en)	2012-05-29
CN101384709A (zh)	2009-03-11
JP2009518370A (ja)	2009-05-07
CN101384709B (zh)	2012-01-04
GB0524884D0 (en)	2006-01-11

Similar Documents

Publication	Publication Date	Title
NZ601868A (en)	2014-05-30	Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
RU2008136324A (ru)	2010-03-20	Желудочно-кишечный пролиферативный фактор и его применения
JP5002603B2 (ja)	2012-08-15	新規なペプチド及びこれの用途
MX2012008999A (es)	2012-08-31	Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340015B (es)	2016-06-22	Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es)	2012-08-31	Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340016B (es)	2016-06-22	Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
NZ602845A (en)	2015-05-29	Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
DE602005020165D1 (de)	2010-05-06	Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
Yang et al.	2024	Effects of collagen hydrolysates on UV-induced photoaging mice: Gly-Pro-Hyp as a potent anti-photoaging peptide
EA201391387A1 (ru)	2014-01-30	Нейропротекторные пептиды
MX2021014497A (es)	2022-02-11	Peptidos.
DE60226323D1 (de)	2008-06-12	Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen
ATE510008T1 (de)	2011-06-15	Entzündungshemmende peptide
NO20081453L (no)	2008-06-10	Sammensetninger og fremgangsmater for diagnostisering og behandling av inflammasjon
NZ562436A (en)	2010-01-29	Toll-like receptor 14 (TLR14) and use thereof
ATE552271T1 (de)	2012-04-15	Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon
NZ591825A (en)	2012-10-26	Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue
ATE544779T1 (de)	2012-02-15	Neue, die migration dendritischer zellen induzierende polypeptide, sowie medikamente und pharmazeutische zusammensetzungen, die diese enthalten
BR0202157A (pt)	2005-04-12	Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo
WO2025062058A3 (es)	2025-05-30	Péptidos y composición farmacéutica como analgésico
DE60329838D1 (de)	2009-12-10	Verwendung von alpha-s2 casein vorläufer-abgeleiteten peptiden
GB201211586D0 (en)	2012-08-15	Japanese cedar peptides for preventing or treating allergy
ATE491947T1 (de)	2011-01-15	Peptid zur hemmung von calcineurin
MXPA04006975A (es)	2004-11-10	Gen humano de la proteasa desubiquitinante del cromosoma 7 y su ortologo murino.

Legal Events

Date	Code	Title	Description
2011-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties